Attentional control in Parkinson's disease is dependent on COMT val 158 met genotype.

No abstract is available for this paper.

• Publication year

  2008

• Venue

  Brain : a journal of neurology

• Publication date

  2008-02-01

• Fields of study

  Medicine, Psychology

• Identifiers
  DOI 10.1093/brain/awm313PMID 18178571
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Region of interest analysis using an SPM toolbox

  2010cited by this paper
• Evolution of cognitive dysfunction in an incident Parkinson's disease cohort.

  2007cited by this paper
• Catechol O-Methyltransferase val158met Genotype Influences Frontoparietal Activity during Planning in Patients with Parkinson's Disease

  2007cited by this paper
• Cortical activity in Parkinson's disease during executive processing depends on striatal involvement.

  2006cited by this paper
• The role of learned irrelevance in attentional set-shifting impairments in Parkinson's disease.

  2006cited by this paper
• Imaging in Parkinson's disease: the role of monoamines in behavior.

  2006cited by this paper
• Dopaminergic modulation of cognitive function-implications for L-DOPA treatment in Parkinson's disease.

  2006cited by this paper
• Explained variation in a model of therapeutic decision making is partitioned across patient, physician, and clinic factors.

  2006cited by this paper
• Under the curve: critical issues for elucidating D1 receptor function in working memory.

  2006cited by this paper
• Fractionating attentional control using event-related fMRI.

  2005cited by this paper
• Cortical regulation of subcortical dopamine systems and its possible relevance to schizophrenia

  2005cited by this paper
• Cognitive profile of patients with newly diagnosed Parkinson disease

  2005cited by this paper
• Dopaminergic basis for deficits in working memory but not attentional set-shifting in Parkinson's disease.

  2005cited by this paper
• Genetic polymorphism of catechol‐O‐methyltransferase and levodopa pharmacokinetic–pharmacodynamic pattern in patients with Parkinson's disease

  2005cited by this paper
• l-Dopa withdrawal in Parkinson's disease selectively impairs cognitive performance in tests sensitive to frontal lobe dysfunction

  2005influential reference
• Midbrain dopamine and prefrontal function in humans: interaction and modulation by COMT genotype

  2005cited by this paper
• Effect of Catechol-O-Methyltransferase val158met Genotype on Attentional Control

  2005cited by this paper
• Genes and the parsing of cognitive processes.

  2004cited by this paper
• Dopamine-Dependent Frontostriatal Planning Deficits in Early Parkinson ' s Disease

  2004cited by this paper
• Functional analysis of genetic variation in catechol-O-methyltransferase (COMT): effects on mRNA, protein, and enzyme activity in postmortem human brain.

  2004cited by this paper
• The cognitive ability of an incident cohort of Parkinson's patients in the UK. The CamPaIGN study.

  2004cited by this paper
• Catechol O-methyltransferase Val158Met polymorphism in schizophrenia: differential effects of Val and Met alleles on cognitive stability and flexibility.

  2004cited by this paper
• Planning ability in Parkinson's disease is influenced by the COMT val158met polymorphism

  2004cited by this paper
• Complexity of prefrontal cortical dysfunction in schizophrenia: more than up or down.

  2003cited by this paper
• Sleepiness in Parkinson's disease: A controlled study

  2003cited by this paper
• Cognitive Impairments in Early Parkinson's Disease Are Accompanied by Reductions in Activity in Frontostriatal Neural Circuitry

  2003cited by this paper
• Catechol O-methyltransferase val158-met genotype and individual variation in the brain response to amphetamine

  2003cited by this paper
• Using executive heterogeneity to explore the nature of working memory deficits in Parkinson's disease.

  2003cited by this paper
• A functional polymorphism in the COMT gene and performance on a test of prefrontal cognition.

  2002cited by this paper
• Computational perspectives on dopamine function in prefrontal cortex.

  2002cited by this paper
• Dopaminergic modulation of cortical function in patients with Parkinson's disease

  2002cited by this paper
• Effects of catecholamine uptake blockers in the caudate-putamen and subregions of the medial prefrontal cortex of the rat.

  2002cited by this paper
• Functional imaging studies of dopamine system and cognition in normal aging and Parkinson's disease.

  2002cited by this paper
• Defining the Neural Mechanisms of Probabilistic Reversal Learning Using Event-Related Functional Magnetic Resonance Imaging

  2002cited by this paper
• Automated Anatomical Labeling of Activations in SPM Using a Macroscopic Anatomical Parcellation of the MNI MRI Single-Subject Brain

  2002cited by this paper
• Increased frontal [(18)F]fluorodopa uptake in early Parkinson's disease: sex differences in the prefrontal cortex.

  2001cited by this paper
• Enhanced or impaired cognitive function in Parkinson's disease as a function of dopaminergic medication and task demands.

  2001cited by this paper
• Effect of COMT Val108/158 Met genotype on frontal lobe function and risk for schizophrenia

  2001cited by this paper
• Dopamine transporter immunoreactivity in monkey cerebral cortex: Regional, laminar, and ultrastructural localization

  2001cited by this paper
• Prefrontal cortex activation in task switching: an event-related fMRI study.

  2000cited by this paper
• The role of prefrontal cortex and posterior parietal cortex in task switching.

  2000cited by this paper
• Frontal, midbrain and striatal dopaminergic function in early and advanced Parkinson's disease A 3D [(18)F]dopa-PET study.

  1999influential reference
• Tryptophan depletion impairs stimulus-reward learning while methylphenidate disrupts attentional control in healthy young adults: implications for the monoaminergic basis of impulsive behaviour

  1999cited by this paper
• Catechol-O-methyltransferase-deficient mice exhibit sexually dimorphic changes in catecholamine levels and behavior.

  1998influential reference
• Abnormal basal ganglia outflow in Parkinson's disease identified with PET. Implications for higher cortical functions.

  1998cited by this paper
• Kinetics of human soluble and membrane-bound catechol O-methyltransferase: a revised mechanism and description of the thermolabile variant of the enzyme.

  1995cited by this paper
• 6-Hydroxydopamine lesions of the prefrontal cortex in monkeys enhance performance on an analog of the Wisconsin Card Sort Test: possible interactions with subcortical dopamine

  1994cited by this paper
• Contrasting mechanisms of impaired attentional set-shifting in patients with frontal lobe damage or Parkinson's disease.

  1993cited by this paper
• A specific form of cognitive rigidity following excitotoxic lesions of the basal forebrain in marmosets.

  1992cited by this paper
• Fronto-striatal cognitive deficits at different stages of Parkinson's disease.

  1992cited by this paper
• Human liver catechol‐O‐methyltransferase pharmacogenetics

  1990cited by this paper
• Impaired extra-dimensional shift performance in medicated and unmedicated Parkinson's disease: evidence for a specific attentional dysfunction.

  1989cited by this paper
• The relevance of the Lewy body to the pathogenesis of idiopathic Parkinson's disease.

  1988cited by this paper
• Psychometric properties of the Beck Depression Inventory: Twenty-five years of evaluation

  1988cited by this paper
• Thermal stability and the biochemical genetics of erythrocyte catechol‐O‐methyltransferase and plasma dopamine‐β‐hydroxylase

  1981cited by this paper
• Catechol-O-methyltransferase: thermolabile enzyme in erythrocytes of subjects homozygous for allele for low activity.

  1979cited by this paper
• A behavioral analysis of degree of reinforcement and ease of shifting to new responses in a Weigl-type card-sorting problem.

  1948cited by this paper
• Brain

  1878cited by this paper

• An Examination of Cognitive Heterogeneity in Parkinson Disease: The Dual-Syndrome Hypothesis.

  2024cites this paper
• Critical evaluation of the current landscape of pharmacogenomics in Parkinson's disease - What is missing? A systematic review.

  2024cites this paper
• Dopamine in the prefrontal cortex plays multiple roles in the executive function of patients with Parkinson's disease

  2023cites this paper
• The epidemiology of cognitive function in Parkinson's disease.

  2022cites this paper
• Genetic variation in the dopamine system is associated with mixed‐strategy decision‐making in patients with Parkinson's disease

  2022cites this paper
• Association Between White Matter Connectivity and Early Dementia in Patients With Parkinson Disease

  2022cites this paper
• @Western Scholarship@Western

  2022cites this paper
• Genetics of cognitive dysfunction in Parkinson's disease.

  2022cites this paper
• Nucleus basalis of Meynert degeneration predicts cognitive impairment in Parkinson's disease.

  2021cites this paper
• A Systematic Review of Parkinson’s Disease Pharmacogenomics: Is There Time for Translation into the Clinics?

  2021cites this paper
• Dissociable effects of age and Parkinson’s disease on instruction-based learning

  2021cites this paper
• Xenobiotic Transport and Metabolism in the Human Brain.

  2021cites this paper
• Brain predictive coding processes are associated to COMT gene Val158Met polymorphism

  2021cites this paper
• Neural Mechanisms of Observational Learning: A Neural Working Model

  2021cites this paper
• Preliminary evidence for the phosphodiesterase type-4 inhibitor, roflumilast, in ameliorating cognitive flexibility deficits in patients with schizophrenia

  2021influential citation
• Cannabinoid Modulation of Dopamine Release During Motivation, Periodic Reinforcement, Exploratory Behavior, Habit Formation, and Attention

  2021cites this paper
• fMRI in Parkinson’s Disease

  2020cites this paper
• Dopamine effects on memory load and distraction during visuospatial working memory in cognitively normal Parkinson’s disease

  2020cites this paper
• Parkinsonian Dementias: PET Findings

  2020cites this paper
• Necessary impairments? The downside of functional compensation in frontostriatal circuits in people with presymptomatic Huntington’s disease

  2020cites this paper
• Factor analysis–derived cognitive profile predicting early dementia conversion in PD

  2020cites this paper
• Optimisation of brain states and behavioural strategies when learning complex tasks

  2020cites this paper
• Experimental protocol: recruitment, power, randomisation, imaging

  2020cites this paper
• Biomarkers Detection of Individual PD Symptoms and Therapeutic Effect Prediction with Machine Learning

  2020cites this paper
• Meta-Analysis of the Effects of the Catechol-O-Methyltransferase Val158/108Met Polymorphism on Parkinson’s Disease Susceptibility and Cognitive Dysfunction

  2019cites this paper
• COMT Val158Met polymorphism associated with greater susceptibility to framing effects in healthy older adults

  2019cites this paper
• Aberrant resting-state oscillatory brain activity in Parkinson's disease patients with visual hallucinations: An MEG source-space study

  2019cites this paper
• Systematic review of genetic variants associated with cognitive impairment and depressive symptoms in Parkinson’s disease

  2019cites this paper
• The Neuropsychiatry of Parkinson Disease: A Perfect Storm.

  2019cites this paper
• More than an “inverted-U”? An exploratory study of the association between the catechol-o-methyltransferase gene polymorphism and executive functions in Parkinson’s disease

  2019cites this paper
• Frontal atrophy as a marker for dementia conversion in Parkinson's disease with mild cognitive impairment

  2019cites this paper
• Can neuroimaging predict dementia in Parkinson’s disease?

  2018cites this paper
• Visuospatial and visuoperceptual impairment and its structural correlates as measures of cognitive decline in parkinson's disease

  2018cites this paper
• Genetic Variation of COMT Impacts Mindfulness and Self-Reported Everyday Cognitive Failures but Not Self-Rated Attentional Control

  2018cites this paper
• Genetic Variation of COMT Impacts Mindfulness and Self-Reported Everyday Cognitive Failures but Not Self-Rated Attentional Control

  2018cites this paper
• Are dementia with Lewy bodies and Parkinson’s disease dementia the same disease?

  2018cites this paper
• Standardised Neuropsychological Assessment for the Selection of Patients Undergoing DBS for Parkinson's Disease

  2018cites this paper
• The Val 158 Met COMT polymorphism is a modifier of the age at onset in Parkinson ' s disease with a sexual dimorphism KLEBE

  2017cites this paper
• Normal aging and Parkinson's disease are associated with the functional decline of distinct frontal-striatal circuits

  2017cites this paper
• Multiple modality biomarker prediction of cognitive impairment in prospectively followed de novo Parkinson disease

  2017cites this paper
• Genetic Variation and Neuroplasticity: Role in Rehabilitation After Stroke.

  2017cites this paper
• Cognition in Parkinson's Disease.

  2017cites this paper
• Risk assessment of aggressive behavior in Chinese patients with schizophrenia by fMRI and COMT gene

  2017cites this paper
• Cognitive impairment and dementia in Parkinson’s disease

  2017cites this paper
• Polymorphisms in dopamine‐associated genes and cognitive decline in Parkinson's disease

  2017cites this paper
• Genetic risk factors for cognitive decline in Parkinson's disease: a review of the literature

  2017cites this paper
• The role of high‐field magnetic resonance imaging in parkinsonian disorders: Pushing the boundaries forward

  2017cites this paper
• Cognitive decline in Parkinson disease

  2017cites this paper
• Pharmacogenetics of Parkinson's Disease in Clinical Practice

  2017cites this paper
• Network mechanisms of intentional learning

  2016cites this paper
• Polymorphisms of dopamine receptor genes and risk of visual hallucinations in Parkinson’s patients

  2016cites this paper
• Catechol-O-methyltransferase Val158Met polymorphism influences prefrontal executive function in early Parkinson's disease.

  2016cites this paper
• Neurocognitive functioning and genetic variation in patients with primary brain tumours.

  2016cites this paper
• COMT Val158Met Polymorphism Modulates Huntington's Disease Progression

  2016cites this paper
• The Genetic Basis of Cognitive Impairment and Dementia in Parkinson’s Disease

  2016cites this paper
• Modulations of Mammalian Brain Functions by Antidepressant Drugs: Role of Some Phytochemicals as Prospective Antidepressants

  2016cites this paper
• Learning to be inflexible: Enhanced attentional biases in Parkinson's disease.

  2016cites this paper
• Executive attention networks show altered relationship with default mode network in PD

  2016cites this paper
• Biomarkers for dementia and mild cognitive impairment in Parkinson's disease

  2016cites this paper
• Clinical Concepts Emerging from fMRI Functional Connectomics.

  2016cites this paper
• Temperamental variation in learned irrelevance in humans

  2015cites this paper
• Parkinson’s disease dementia: a neural networks perspective

  2015influential citation
• 1 Network mechanisms of intentional learning

  2015cites this paper
• Differential optimal dopamine levels for set-shifting and working memory in Parkinson's disease.

  2015cites this paper
• Clinical implications of neuropharmacogenetics.

  2015cites this paper
• Does Response Inhibition Have Pre- and Postdiagnostic Utility in Parkinson's Disease?

  2015cites this paper
• Cortical dynamics and subcortical signatures of motor-language coupling in Parkinson’s disease

  2015cites this paper
• Molecular and genetic basis of depression

  2014cites this paper
• Influence du polymorphisme nucléotidique COMT sur la mémoire de travail et son vieillissement

  2014cites this paper
• Dopamine transporter SLC6A3 genotype affects cortico-striatal activity of set-shifts in Parkinson's disease.

  2014cites this paper
• Neurocognitive changes in early-stage Parkinson's disease : functional and structural brain correlates of memory and verbal functions

  2014cites this paper
• Attention shifting in Parkinson's disease: an analysis of behavioral and cortical responses.

  2014cites this paper
• Mild cognitive impairment in Parkinson's disease is associated with a distributed pattern of brain white matter damage

  2014cites this paper
• Transcranial magnetic stimulation and transcranial direct current stimulation: treatments for cognitive and neuropsychiatric symptoms in the neurodegenerative dementias?

  2014cites this paper
• Parkinson Dementia: PET Findings

  2014cites this paper
• Dopamine transporter SLC 6 A 3 genotype affects cortico-striatal activity of set-shifts in Parkinson ’ s disease

  2014cites this paper
• The neurobiological basis of cognitive impairment in Parkinson's disease

  2014cites this paper
• Risk Factors for Levodopa-Induced Dyskinesia

  2014cites this paper
• Physiopathologie des troubles de la sélectivité attentionnelle dans la maladie de Parkinson : rôle des processus de capture et de contrôle volontaire de l'attention

  2014cites this paper
• Dopaminergic influences on executive function and impulsive behaviour in impulse control disorders in Parkinson's disease.

  2013cites this paper
• Use of the Gait Deviation Index and spatiotemporal variables for the assessment of dual task interference paradigm.

  2013cites this paper
• Dual Task Performance in Parkinson’s Disease

  2013cites this paper
• Prefrontal dopamine levels determine the balance between cognitive stability and flexibility.

  2013influential citation
• The CamPaIGN study of Parkinson's disease: 10-year outlook in an incident population-based cohort

  2013cites this paper
• Motor-language coupling: direct evidence from early Parkinson's disease and intracranial cortical recordings.

  2013cites this paper
• Striatal volume is related to phonemic verbal fluency but not to semantic or alternating verbal fluency in early Parkinson’s disease

  2013cites this paper
• Mild Cognitive Impairment in Parkinson's Disease: A Review of Current Concepts

  2013cites this paper
• Dopamine overdose hypothesis: Evidence and clinical implications

  2013cites this paper
• Magnetic resonance imaging: A biomarker for cognitive impairment in Parkinson's disease?

  2013cites this paper
• Behavior genetics: Past, present, future

  2013cites this paper
• Prefrontal dopamine signaling and cognitive symptoms of Parkinson’s disease

  2013cites this paper
• Pharmacogenomics and Personalized Medicine in Parkinsonism

  2013cites this paper
• Putative cortical dopamine levels affect cortical recruitment during planning

  2013cites this paper
• Management of psychosis and dementia

  2013cites this paper
• Association Between Catechol-O-Methyltransferase (COMT) Gene Polymorphisms, Parkinson’s Disease, and Levodopa Efficacy

  2013cites this paper
• The Effect of COMT Gene Polymorphism on the Neural Substrate of Attention Control: A Meta-analysis of Imaging Genetics Studies

  2013influential citation
• Neuroimaging of brain changes associated with cognitive impairment in Parkinson's disease.

  2013cites this paper
• The Val158Met COMT polymorphism is a modifier of the age at onset in Parkinson's disease with a sexual dimorphism

  2013cites this paper
• Executive dysfunction in Parkinson's disease: a review.

  2013cites this paper
• Task-dependent interactions between dopamine D2 receptor polymorphisms and L-DOPA in patients with Parkinson's disease.

  2013cites this paper